PROCEPT BioRobotics announced on July 24, 2025, that Dr. Reza Zadno will retire as President, CEO, and director, effective September 1, 2025. Dr. Zadno led the company through significant growth, commercial expansion, and the initiation of prostate cancer clinical trials over the past five years.
Larry L. Wood, an accomplished executive with over 40 years of experience in the medical technology industry, including leadership roles at Edwards Lifesciences, will succeed Dr. Zadno as President and CEO, effective September 2, 2025. Mr. Wood joined PROCEPT BioRobotics' board of directors in 2024.
In connection with this announcement, the company also pre-announced its second-quarter 2025 revenue, which is expected to be approximately $79.2 million. This pre-announcement indicates continued strong financial performance ahead of the official Q2 earnings report scheduled for August 6, 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.